361556 Sigma-AldrichGSK-3 Inhibitor IX, Control, MeBIO - CAS 710323-61-8 - Calbiochem
The GSK-3 Inhibitor IX, Control, MeBIO, also referenced under CAS 710323-61-8, controls the biological activity of GSK-3. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
More>> The GSK-3 Inhibitor IX, Control, MeBIO, also referenced under CAS 710323-61-8, controls the biological activity of GSK-3. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Less<<FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Synonymes: 1-Methyl-BIO
Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| CAS # | Empirical Formula |
|---|---|
| 710323-61-8 | C₁₇H₁₂BrN₃O₂ |
Products
| Référence | Conditionnement | Qté | |
|---|---|---|---|
| 361556-1MG | Ampoule plast. | 1 mg |
| Description | |
|---|---|
| Overview | A cell-permeable N-methylated analog of GSK-3 Inhibitor IX, BIO (Cat. No. 361550) that serves as a relevant kinase inactive control (IC50 > 92 µM for Cdk1/B, > 100 µM for Cdk5/p25, and GSK-3α/β). Acts as a potent ligand for aryl hydrocarbon receptor (AhR; EC50 = 20 nM and 93 nM for yeast and hepatoma reporter systems, respectively) and displays antiproliferative properties. |
| Catalogue Number | 361556 |
| Brand Family | Calbiochem® |
| Synonyms | 1-Methyl-BIO |
| References | |
|---|---|
| References | Knockaert, M., et al. 2004. Oncogene 23, 4400. Polychronopoulos, P., et al. 2004. J. Med. Chem. 47, 935. Meijer, L., et al. 2003. Chem. Biol. 10, 1255. |
| Product Information | |
|---|---|
| CAS number | 710323-61-8 |
| ATP Competitive | N |
| Form | Dark red solid |
| Hill Formula | C₁₇H₁₂BrN₃O₂ |
| Chemical formula | C₁₇H₁₂BrN₃O₂ |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Relevant kinase inactive control |
| Primary Target IC<sub>50</sub> | > 92 µM for Cdk1/B, > 100 µM for Cdk5/p25, and GSK-3α/β |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 361556-1MG | 04055977214161 |
Documentation
GSK-3 Inhibitor IX, Control, MeBIO - CAS 710323-61-8 - Calbiochem FDS
| Titre |
|---|
GSK-3 Inhibitor IX, Control, MeBIO - CAS 710323-61-8 - Calbiochem Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 361556 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Knockaert, M., et al. 2004. Oncogene 23, 4400. Polychronopoulos, P., et al. 2004. J. Med. Chem. 47, 935. Meijer, L., et al. 2003. Chem. Biol. 10, 1255. |